Total Payments
$11,722
2024 Payments
$1,929
Companies
45
Transactions
726
Medicare Patients
13,323
Medicare Billing
$1.5M
Payment Breakdown by Category
Food & Beverage$11,690 (99.7%)
Education$31.83 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,690 | 722 | 99.7% |
| Education | $31.83 | 4 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,625 | 103 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,606 | 118 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,207 | 69 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,114 | 69 | $0 (2024) |
| Novo Nordisk Inc | $1,031 | 106 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $751.31 | 46 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $560.13 | 26 | $0 (2024) |
| Boston Scientific Corporation | $434.11 | 23 | $0 (2024) |
| PFIZER INC. | $422.37 | 23 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $312.11 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,929 | 99 | Boehringer Ingelheim Pharmaceuticals, Inc. ($339.94) |
| 2023 | $1,810 | 97 | Boehringer Ingelheim Pharmaceuticals, Inc. ($284.67) |
| 2022 | $1,993 | 141 | Boehringer Ingelheim Pharmaceuticals, Inc. ($417.99) |
| 2021 | $1,266 | 87 | Boehringer Ingelheim Pharmaceuticals, Inc. ($268.14) |
| 2020 | $1,014 | 64 | Amgen Inc. ($226.15) |
| 2019 | $1,358 | 82 | Amgen Inc. ($319.48) |
| 2018 | $1,217 | 91 | Amgen Inc. ($317.58) |
| 2017 | $1,134 | 65 | Novartis Pharmaceuticals Corporation ($205.72) |
All Payment Transactions
726 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.25 | General |
| Category: Cardiovascular | ||||||
| 12/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $27.62 | General |
| Category: Cardiology | ||||||
| 12/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Cardio-renal | ||||||
| 12/04/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Transcatheter Heart Valves | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $7.74 | General |
| Category: Cardiovascular | ||||||
| 11/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: Cardio-renal | ||||||
| 11/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: DIABETES | ||||||
| 11/12/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $22.68 | General |
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.59 | General |
| Category: Cardiovascular | ||||||
| 10/30/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Cardiology | ||||||
| 10/16/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $23.84 | General |
| Category: Cardiovascular | ||||||
| 10/01/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $20.78 | General |
| Category: Cardiovascular | ||||||
| 09/26/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Cardiology | ||||||
| 09/11/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Genetic Disease | ||||||
| 09/10/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $23.41 | General |
| Category: Cardiovascular | ||||||
| 08/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Cardio-renal | ||||||
| 08/27/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Obesity | ||||||
| 08/27/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $8.84 | General |
| Category: Cardiovascular | ||||||
| 08/26/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $20.81 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 2,877 | 4,750 | $1.2M | $291,807 |
| 2022 | 21 | 3,165 | 5,514 | $1.3M | $319,012 |
| 2021 | 26 | 3,355 | 6,266 | $1.3M | $372,014 |
| 2020 | 23 | 3,926 | 7,866 | $1.7M | $468,141 |
Total Patients
13,323
Total Services
24,396
Medicare Billing
$1.5M
Procedure Codes
95
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 920 | 1,920 | $703,780 | $173,275 | 24.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 354 | 356 | $211,796 | $52,305 | 24.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 207 | 207 | $98,432 | $24,039 | 24.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 194 | 194 | $42,403 | $10,827 | 25.5% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 78 | 456 | $15,048 | $3,618 | 24.0% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 70 | 93 | $14,106 | $3,565 | 25.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 71 | 73 | $14,339 | $3,365 | 23.5% |
| Q9957 | Injection, perflutren lipid microspheres, per ml | Office | 2023 | 35 | 70 | $11,194 | $2,526 | 22.6% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 31 | 40 | $9,232 | $2,441 | 26.4% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 115 | 120 | $9,018 | $2,248 | 24.9% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 55 | 93 | $7,998 | $1,922 | 24.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 171 | 177 | $7,682 | $1,874 | 24.4% |
| 93017 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) | Office | 2023 | 79 | 79 | $8,276 | $1,852 | 22.4% |
| 85610 | Blood test, clotting time | Office | 2023 | 75 | 406 | $5,530 | $1,705 | 30.8% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 58 | 96 | $6,722 | $1,574 | 23.4% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 80 | 80 | $4,929 | $1,126 | 22.8% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 110 | 116 | $4,804 | $1,065 | 22.2% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 43 | 43 | $2,933 | $771.54 | 26.3% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 79 | 79 | $3,209 | $765.10 | 23.8% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 11 | 11 | $2,620 | $550.30 | 21.0% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 41 | 41 | $1,697 | $392.43 | 23.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 961 | 1,986 | $724,487 | $178,714 | 24.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 359 | 364 | $208,516 | $53,676 | 25.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 289 | 289 | $137,120 | $33,798 | 24.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 165 | 165 | $35,965 | $9,294 | 25.8% |
About Dr. Michael Hegewald, M.D
Dr. Michael Hegewald, M.D is a Internal Medicine healthcare provider based in Silverdale, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427080282.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Hegewald, M.D has received a total of $11,722 in payments from pharmaceutical and medical device companies, with $1,929 received in 2024. These payments were reported across 726 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($11,690).
As a Medicare-enrolled provider, Hegewald has provided services to 13,323 Medicare beneficiaries, totaling 24,396 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease
- Location Silverdale, WA
- Active Since 07/06/2006
- Last Updated 03/07/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1427080282
Products in Payments
- JARDIANCE (Drug) $1,481
- Repatha (Biological) $1,245
- ENTRESTO (Drug) $1,005
- ELIQUIS (Drug) $780.41
- BRILINTA (Drug) $738.79
- Kerendia (Drug) $560.13
- Ozempic (Drug) $425.85
- Vascepa (Drug) $274.88
- XARELTO (Drug) $274.33
- FARXIGA (Drug) $256.36
- Rybelsus (Drug) $251.05
- CAMZYOS (Drug) $249.34
- WATCHMAN (Device) $248.29
- LOKELMA (Drug) $239.35
- VERQUVO (Drug) $228.45
- Arcalyst (Drug) $212.60
- Impella (Device) $175.73
- SAMSCA (Drug) $138.34
- NORTHERA (Drug) $127.72
- Prolia (Biological) $124.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Silverdale
Toni Terry, M.d, M.D
Internal Medicine — Payments: $12,635
Internal Medicine $12,635
Marissa Anderson-Chernishof, M.d., M.s, M.D., M.S
Internal Medicine — Payments: $11,129
Internal Medicine $11,129
Kittredge Baldwin, D.o, D.O
Internal Medicine — Payments: $10,884
Internal Medicine $10,884
John Banzer, M.d, M.D
Internal Medicine — Payments: $10,806
Internal Medicine $10,806
Dr. William Hall, M.d, M.D
Internal Medicine — Payments: $9,498
Internal Medicine $9,498
Kim Kuhar
Internal Medicine — Payments: $2,954
Internal Medicine $2,954